The standard titration increases the dose by 2.5 mg every 4 weeks, though some patients may benefit from slower advancement
Gray, E
This neurotoxic environment is believed to be a primary driver of the debilitating cognitive dysfunction, or 'brain fog,' that patients experience daily
GLP-1 Medications Show Promise for Improving HS Symptoms February 23, 2026 Authors: Allison Hanka, College of Biological Sciences, University of Minnesota, Minneapolis, MN Jordyn Nepper, BS, Department of Dermatology, University of Minnesota, Minneapolis, MN Noah Goldfarb, MD, Associate Professor, Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN Why was this research done